Survival Rate

In patients with pulmonary fibrosis, consuming omega-3 fatty acids may improve diffusing capacity for carbon monoxide and lengthen survival, according to results published in CHEST.

In this video, Akriti Jain, MD, discusses the results of a study on treatment patterns and outcomes for patients with acute myeloid Leukemia , which showed that outcomes improved over the past decade.

Patients who died of a COVID-19 and tuberculosis coinfection had a shorter median time to death compared with patients who died of either COVID-19 or TB alone, according to results published in European Respiratory Journal.

Patients with bronchopulmonary dysplasia who received a lung transplant showed survival rates comparable to those of transplant recipients with other lung diseases, according to results published in CHEST.

Patients with severe alpha-1 antitrypsin deficiency had improved survival with intravenous plasma-purified alpha-1 antitrypsin therapy, according to results published in American Journal of Respiratory and Critical Care Medicine.

Patients with COVID-19-related acute respiratory distress syndrome undergoing transplantation had comparable, high survival rates to patients with COVID-19-related pulmonary fibrosis, according to results published in JAMA Surgery.

Patients with Merkel cell carcinoma may have better survival outcomes when treated with Mohs micrographic surgery compared with wide local excision, according to a study.

Patients with cystic fibrosis had an average survival of 66 years in 2022, which is a notable increase from 26 years in 2008, according to study results from Epic Research.

Patients diagnosed with systemic sclerosis-related pulmonary hypertension in the last 10 years had better survival than those diagnosed prior, according to results published in American Journal of Respiratory and Critical Care Medicine.

Adolescents and young adults with stage IV melanoma experienced significantly lower survival rates compared with older adults, according to a study.